According to the GP targetes magazine Pulse, a study in the US has shown that Metformin, for patients with Type 2 diabetes, offers some protection against pancreatic cancer. So that's good news. Patients with diabetes who had taken metformin had a 62% lower risk of pancreatic cancer than those who had not.
Who knows how good these studies actually are, but it's an interesting revelation. All they need to do now is find out why.
These are Andy Kliman's personal views, experiences and opinions and do not necessarily reflect those of Diabetes UK